Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 25, 2025
AVA Dental Introduces Biomimetic, Nature-Inspired Dentistry to Support Oral Health in Westfield
EIN Presswire
·
April 25, 2025
Dr. Jonathan Asimakopoulos of AVA Dental helps Westfield residents benefit from biomimetic dentistry—focused on preserving natural teeth, long-term oral health. WESTFIELD, IN, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- A growing number of …
Rezolute, Inc. Announces Closing of Underwritten Offering
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing …
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis
GlobeNewswire
·
April 25, 2025
FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous and …
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
GlobeNewswire
·
April 25, 2025
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory …
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
GlobeNewswire
·
April 25, 2025
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) …
Prelude Announces Presentations at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, …
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
GlobeNewswire
·
April 25, 2025
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …
SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025
GlobeNewswire
·
April 25, 2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (NYSE American: BTTR) (the “Company”), a leading global health and wellness company, today announced that it will distribute (the “ …
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
GlobeNewswire
·
April 25, 2025
Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co- …
EPC-RPU: AI-Powered Embedded System for Automation, Retail, and Healthcare
EIN Presswire
·
April 25, 2025
TAIPEI, TAIWAN, April 25, 2025 /EINPresswire.com/ -- Avalue Technology Inc. (TAIEX: 3479-TW), a global leader in industrial computing solutions, has officially announced its latest high-performance embedded system EPC-RPU, featuring the Intel® 13th …
Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development
GlobeNewswire
·
April 25, 2025
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and pharma companies to leverage Spanios’ …
Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)
GlobeNewswire
·
April 25, 2025
New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such pill is Clenbuterol, which is often used for weight loss. However, Clenbuterol …
Board Certified Plastic Surgeon, Clark Schierle, MD, PhD, FACS Approved As 2025 IL Top Doc
EIN Presswire
·
April 25, 2025
Dr. Clark Schierle of Northwestern Specialists in Plastic Surgery has been reviewed and approved based on merit by IL Top Docs for 2025. CHICAGO, IL, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Board Certified Plastic Surgeon, Clark Schierle, MD …
Board Certified Dermatologist, Dr. Adriana Lombardi Awarded As 2025 NJ Top Doc
EIN Presswire
·
April 25, 2025
NJ Top Docs has reviewed and approved Dr. Adriana Lombardi based on merit for 2025. EDISON, NJ, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Board Certified Dermatologist, Dr. Adriana Lombardi Awarded As 2025 NJ Top Doc NJ Top Docs has …
Best Probiotics For Women: Top-Rated Picks for Digestion, Mood, and Immunity Announced By WhatBest.
GlobeNewswire
·
April 25, 2025
New York, April 25, 2025 (GLOBE NEWSWIRE) -- WhatBest, a leading authority known for meticulous, research-based evaluations of health and wellness products, is excited to announce its comprehensive list of the best probiotics specifically chosen for women. …
Tevogen Bio Announces 2025 Annual Meeting
GlobeNewswire
·
April 25, 2025
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …
NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1
EIN Presswire
·
April 25, 2025
Confirmation of NP137 Potential to Overcome Resistance to Immune Checkpoint - Clinical Trial Design and Interim Results to be Presented at ASCO and ESMO 2025 LYON, FRANCE, April 25, 2025 /EINPresswire.com/ -- NETRIS Pharma, a clinical-stage private …
New Book Explores the Role of AI, Telemedicine, and Big Data in Modern Healthcare
EIN Presswire
·
April 25, 2025
Explore how AI, big data, and telemedicine are revolutionizing healthcare in Tedrick Bairn’s groundbreaking new book, Digital Healthcare. NEW YORK, NY, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- As healthcare systems worldwide struggle with …
Decision Pulse AI By office solution : An GEN AI solution which outperform McKinsey BCG and BAIN consultant
EIN Presswire
·
April 25, 2025
GURUGRAM, HARYANA, INDIA, April 25, 2025 /EINPresswire.com/ -- Office Solution is excited to announce the availability of Decision Pulse AI on Microsoft AppSource, the trusted marketplace for business-ready applications. Built to empower enterprise …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …